Data mostly coming from Japanese and Asian studies indicate that elevated KL-6 levels in serum are also associated with the risk of disease progression and mortality in ILD [13], but further studies are needed to validate these promising results in Caucasians. The gene discussed is MUC1; the disease is interstitial lung disease.